Mia Minen, MD, MPH

“There are no FDA-approved medications for concussion or posttraumatic headache, and we really don’t have good treatments in general.”

Mia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.

Minen, an assistant professor of neurology and director of headache services at NYU Langone, pointed to the lack of effective treatments and FDA-approved therapies for this headache sub-type.

In this interview, she discusses the creation of an accessible digital platform that can help patients track their symptoms and receive progressive muscle relaxation therapy.

Videos

Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache 

“Migraine is the second most disabling condition, and there are over 36 million Americans who have migraine.”

At the 2019 American Academy of Neurology Annual Meeting, Mia Minen, MD, MPH, sat down with 

 to discuss the behavioral therapies for treating migraine.

Minen, an assistant professor of neurology and director of headache services at NYU Langone, stressed that while behavioral treatments for migraine are effective, they are not often utilized.

Patients often encounter issues with treatment access or cost as well as issues surrounding migraine stigma. Minen discussed ways to better incorporate this treatment and strategies to improve payor compliance.

At the 2019 American Academy of Neurology Conference, Mia Minen, MD, MPH took the time to sit down and discuss the behavioral therapies associated with treating migraine.

Mia Minen, MD, MPH: Incorporating Behavioral Treatment for Migraine

“We have tried to leverage the increased use of smartphone technology to try to increase access to scalable, accessible forms of migraine treatments.”

At the 2019 American Academy of Neurology Annual Meeting, Mia Minen, MD, MPH, discussed the opportunities that the increasing number of mobile health users presents for migraine treatment.

Minen pointed out that about half of the 3.4 billion smartphone users have health-related applications on their device. She discussed findings from her study on the RELAXaHEAD mobile app, where users can track their symptoms and receive behavioral therapy to help relieve pain and reduce their migraine frequency.

In this interview, Minen shared her expertise on how these applications can be leveraged to improve access to and use of behavioral migraine treatments.

Mia Minen, MD, MPH

Articles

Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache

Mia Minen, MD, MPH: Incorporating Behavioral Treatment for Migraine

Mia Minen, MD, MPH: Mobile Health in Migraine Treatment